GlaxoSmithKline Japan Review

About GlaxoSmithKline Japan

GlaxoSmithKline Japan: A Global Healthcare Company with a Scientific Approach

GlaxoSmithKline (GSK) is a global healthcare company that is committed to improving the quality of life for people around the world. With a scientific approach to healthcare, GSK aims to help people live longer, healthier lives by providing innovative and effective treatments for a range of medical conditions.

Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has become one of the largest pharmaceutical companies in the world. Headquartered in London, UK, GSK operates in more than 150 countries and employs over 100,000 people worldwide.

In Japan, GSK has been operating since 1989 and has established itself as a leading provider of innovative healthcare solutions. With a focus on research and development (R&D), GSK Japan is dedicated to discovering new treatments for diseases that affect millions of people around the world.

GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer. To achieve this goal, GSK invests heavily in R&D activities aimed at developing new medicines and vaccines that can address some of today's most pressing health challenges.

One area where GSK has made significant progress is in respiratory medicine. The company's portfolio includes several leading respiratory products such as Seretide/Advair (fluticasone propionate/salmeterol xinafoate), which helps patients manage their asthma symptoms more effectively.

Another area where GSK has made significant contributions is in vaccines. The company produces vaccines for diseases such as hepatitis A & B, influenza, meningitis C and HPV (human papillomavirus). These vaccines have helped prevent millions of cases worldwide and have saved countless lives.

In addition to its focus on R&D activities, GSK also places great emphasis on corporate social responsibility (CSR). The company believes that it has an obligation to contribute positively to society by supporting initiatives that promote health education and disease prevention.

For example, through its partnership with Save the Children International (SCI), GSK supports programs aimed at improving maternal health outcomes in developing countries. In addition, through its "Orange Days" initiative launched globally every year since 2013 during which employees volunteer their time towards community service projects focused on improving access or awareness about healthcare issues affecting local communities across different regions including Asia Pacific region including Japan

Overall,GlaxoSmithKline Japan continues its commitment towards innovation-driven growth while contributing positively towards society through CSR initiatives aimed at promoting better health outcomes globally